Nexgel Inc (NXGL) Stock Price, Quote & News

Company Profile

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin;...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 215 702 8550

Website: nexgel.com

Address:

2150 Cabot Boulevard West, Suite B, Langhorne, United States

BaronVonWulkenstien Jun. 16 at 12:56 PM

$NXGL What the heck is going on here? Not complaining, but a bit bemused.

1 · Reply

Mjacpa Jun. 15 at 4:20 AM

$LGCY finally accumulated enough to say im in on this name. $NXGL $STXS $CRAWA $ACFN are my top holdings

0 · Reply

Mjacpa Jun. 15 at 4:18 AM

$NXGL very curious to see how this trades monday after fridays volume.

0 · Reply

WillieWill Jun. 13 at 7:01 PM

$NXGL Abbvie?

1 · Reply

JoshForc Jun. 13 at 3:50 PM

$NXGL actually, maybe today is the day ;-)

1 · Reply

JoshForc Jun. 11 at 1:19 PM

$NXGL today the day?!?

0 · Reply

Stocksniperwhale Jun. 4 at 3:22 PM

$NXGL Nice ! BAKE US MONEY

0 · Reply

Klinsmann Jun. 3 at 8:38 AM

$NXGL nice reversal in the making

0 · Reply

Stocksniperwhale Jun. 2 at 11:42 PM

$ALZN forget about it $NXGL as the potential to run to 10$+ golden ticket to Lamborghini don’t sleep on this one gonna pump in AH or PM !

0 · Reply

Stocksniperwhale Jun. 2 at 11:37 PM

$SISI $NXGL THIS ONE IS THE NEXT BOOM AH

0 · Reply

NEXGEL, Inc. (NXGL) Q1 2025 Earnings Call Transcript

May 9, 2025, 9:00 AM EDT - 5 weeks ago

NEXGEL to Report First Quarter 2025 Financial Results on May 13th

Mar 24, 2025, 5:41 PM EDT - 2 months ago

NEXGEL, Inc. (NXGL) Q4 2024 Earnings Call Transcript

Mar 24, 2025, 4:05 PM EDT - 2 months ago

NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results

Mar 19, 2025, 9:00 AM EDT - 3 months ago

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th

Feb 13, 2025, 9:00 AM EST - 4 months ago

NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025

Jan 2, 2025, 9:00 AM EST - 5 months ago

NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer

Nov 13, 2024, 10:56 PM EST - 7 months ago

NEXGEL, Inc. (NXGL) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:40 PM EST - 7 months ago

NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially

Nov 11, 2024, 5:35 PM EST - 7 months ago

NEXGEL Announces $2,000,000 Registered Direct Offering

Oct 11, 2024, 9:00 AM EDT - 8 months ago

NEXGEL to Participate in Upcoming October Investor Conferences

Oct 4, 2024, 9:00 AM EDT - 9 months ago

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

Aug 14, 2024, 9:01 PM EDT - 10 months ago

NEXGEL, Inc. (NXGL) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:25 PM EDT - 10 months ago

NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million

Aug 12, 2024, 9:15 AM EDT - 11 months ago

NEXGEL to Report Second Quarter 2024 Financial Results on August 14th

Jul 18, 2024, 9:15 AM EDT - 11 months ago

NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal

Jul 8, 2024, 4:05 PM EDT - 1 year ago

NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively

Jun 11, 2024, 8:40 AM EDT - 1 year ago

NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America

May 16, 2024, 9:00 AM EDT - 1 year ago

NEXGEL Acquires International Beauty Brand, Silly George

May 13, 2024, 6:35 PM EDT - 1 year ago

NEXGEL, Inc. (NXGL) Q1 2024 Earnings Call Transcript

Apr 1, 2024, 2:25 PM EDT - 1 year ago

NEXGEL, Inc. (NXGL) Q4 2023 Earnings Call Transcript

Apr 1, 2024, 7:50 AM EDT - 1 year ago

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

Mar 27, 2024, 9:00 AM EDT - 1 year ago

NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday

Mar 21, 2024, 9:00 AM EDT - 1 year ago

NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

Mar 4, 2024, 8:30 AM EST - 1 year ago

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

Jan 9, 2024, 8:30 AM EST - 1 year ago

NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024

Dec 11, 2023, 8:00 AM EST - 1 year ago

NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America

Nov 17, 2023, 2:27 PM EST - 1 year ago

NEXGEL, Inc. (NXGL) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 4:05 PM EST - 1 year ago

NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year

Sep 26, 2023, 9:49 AM EDT - 1 year ago

NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd

Aug 17, 2023, 6:01 PM EDT - 1 year ago

NEXGEL, Inc. (NXGL) Q2 2023 Earnings Call Transcript

Aug 2, 2023, 9:00 AM EDT - 2 years ago

NEXGEL to Report Second Quarter 2023 Financial Results on August 14th

Jul 19, 2023, 9:10 AM EDT - 2 years ago

NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North America

Jun 15, 2023, 9:00 AM EDT - 2 years ago

NEXGEL to Participate in Maxim Group's Virtual Healthcare Conference on June 20th

May 24, 2023, 9:00 AM EDT - 2 years ago

NEXGEL to Participate in the LD Micro Invitational XIII on June 6th

May 9, 2023, 9:15 AM EDT - 2 years ago

NEXGEL to Report First Quarter 2023 Financial Results on May 15th

Mar 27, 2023, 4:05 PM EDT - 2 years ago

NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 15, 2023, 7:30 AM EDT - 2 years ago

NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th

Mar 7, 2023, 7:30 AM EST - 2 years ago

NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard

Mar 2, 2023, 8:30 AM EST - 2 years ago

NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business

Jan 17, 2023, 7:30 AM EST - 2 years ago

NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee

Dec 8, 2022, 7:30 AM EST - 2 years ago

NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds

Dec 7, 2022, 7:30 AM EST - 2 years ago

NEXGEL Announces Share Repurchase Program

Dec 1, 2022, 11:00 AM EST - 2 years ago

NEXGEL to Host Fireside Chat with CEO Adam Levy on December 14th at 11:00 a.m. ET

Nov 8, 2022, 4:11 PM EST - 2 years ago

NEXGEL Reports Third Quarter 2022 Financial Results

Nov 2, 2022, 9:00 AM EDT - 2 years ago

NEXGEL to Report Third Quarter 2022 Financial Results on November 8th

Oct 4, 2022, 7:30 AM EDT - 2 years ago

NEXGEL to Participate in Upcoming Investor Conferences in October 2022

Oct 3, 2022, 7:30 AM EDT - 2 years ago

SAGE Journals Publishes New Data Revealing NEXGEL's SilverSeal Hydrogel Dressing Improves Postsurgical Scarring

Sep 29, 2022, 7:30 AM EDT - 2 years ago

NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board

Sep 7, 2022, 7:30 AM EDT - 3 years ago

NEXGEL to Present at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022

BaronVonWulkenstien Jun. 16 at 12:56 PM

$NXGL What the heck is going on here? Not complaining, but a bit bemused.

1 · Reply

Mjacpa Jun. 15 at 4:20 AM

$LGCY finally accumulated enough to say im in on this name. $NXGL $STXS $CRAWA $ACFN are my top holdings

0 · Reply

Mjacpa Jun. 15 at 4:18 AM

$NXGL very curious to see how this trades monday after fridays volume.

0 · Reply

WillieWill Jun. 13 at 7:01 PM

$NXGL Abbvie?

1 · Reply

JoshForc Jun. 13 at 3:50 PM

$NXGL actually, maybe today is the day ;-)

1 · Reply

JoshForc Jun. 11 at 1:19 PM

$NXGL today the day?!?

0 · Reply

Stocksniperwhale Jun. 4 at 3:22 PM

$NXGL Nice ! BAKE US MONEY

0 · Reply

Klinsmann Jun. 3 at 8:38 AM

$NXGL nice reversal in the making

0 · Reply

Stocksniperwhale Jun. 2 at 11:42 PM

$ALZN forget about it $NXGL as the potential to run to 10$+ golden ticket to Lamborghini don’t sleep on this one gonna pump in AH or PM !

0 · Reply

Stocksniperwhale Jun. 2 at 11:37 PM

$SISI $NXGL THIS ONE IS THE NEXT BOOM AH

0 · Reply

Stocksniperwhale Jun. 2 at 11:35 PM

$ALZN NEXT IS $NXGL JUMP IN BEFORE IT TAKE OFF super low float

0 · Reply

Chiroptera_Capital May. 28 at 4:10 PM

$NXGL pretty bullish on the company but tough to buy when dilution seems never-ending

0 · Reply

b11gcy May. 21 at 11:04 PM

$NXGL can we get @jacksparo on this one to get this to pump pls ...when will this hit doube digits?

0 · Reply

KFace May. 15 at 4:46 PM

$NXGL lol I’m out with a $100 loss. Fuck this lol. Great earnings beat everything everytime and they still keep it down “bullish sentiment” lol with only me commenting pretty much says it all

0 · Reply

BigDaddyDag1oo May. 14 at 10:05 AM

$NXGL Let’s go!!

0 · Reply

LeverUp19 May. 13 at 9:15 PM

$NXGL Abbvie deal keeps getting pushed out. Very frustrating despite otherwise good performance.

1 · Reply

KFace May. 13 at 8:54 PM

$NXGL sheeesh there’s this guy asking like 1,000 questions 😂

0 · Reply

KFace May. 13 at 8:31 PM

$NXGL

0 · Reply

KFace May. 7 at 1:55 PM

$NXGL lol they will beat earnings again

0 · Reply

KFace May. 6 at 12:38 PM

$NXGL come on!!

0 · Reply

KFace Apr. 30 at 8:22 PM

$NXGL all you need to know

0 · Reply

KFace Apr. 30 at 8:11 PM

$NXGL $5 incoming get ready for the 12th!

1 · Reply

Market Cap	19.60M
Revenue (ttm)	8.69M
Net Income (ttm)	-3.28M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-37.74%
Debt to Equity Ratio	0.00

Volume	162,400
Avg Vol	38,910
Day's Range	N/A - N/A
Shares Out	7.66M
Stochastic %K	70%
Beta	0.52
Analysts	Strong Sell
Price Target	$6.00